- Home
- FWONK vs WST Comparison
FWONK vs WST Comparison
Compare FWONK & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FWONK | WST |
|---|---|---|
| Founded | 1950 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.8B | 17.9B |
| IPO Year | N/A | 2004 |
Fundamental Metrics
Financial Performance| Metric | FWONK | WST |
|---|---|---|
| Price | $83.80 | $235.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | $111.00 | ★ $319.43 |
| AVG Volume (30 Days) | ★ 2.2M | 778.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.38% |
| EPS Growth | N/A | ★ 1.49 |
| EPS | N/A | ★ 6.79 |
| Revenue | N/A | ★ $2,886,900,000.00 |
| Revenue This Year | $24.56 | $6.73 |
| Revenue Next Year | $9.89 | $6.07 |
| P/E Ratio | $107.00 | ★ $34.07 |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $75.26 | $187.43 |
| 52 Week High | $109.36 | $322.34 |
Technical Indicators
Market Signals| Indicator | FWONK | WST |
|---|---|---|
| Relative Strength Index (RSI) | 42.96 | 42.34 |
| Support Level | $82.40 | $225.66 |
| Resistance Level | $100.43 | $251.73 |
| Average True Range (ATR) | 3.49 | 6.49 |
| MACD | -0.24 | -1.16 |
| Stochastic Oscillator | 25.48 | 21.27 |
Price Performance
Historical ComparisonAbout FWONK Liberty Media Corporation Series C Liberty Formula One
Liberty Media Corp along with its subsidiaries is engaged in the media and entertainment industries in North America and the United Kingdom. The company owns interests in a high-quality portfolio of assets across the media, entertainment and sports industries. The company derives its maximum revenue from United Kingdom.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.